The global dyslipidemia treatment market is experiencing significant development in the coming years. This phenomenon can be attributed to a rising prevalence of cardiovascular diseases, coupled with a larger proportion of older individuals. The market is heavily influenced by key players who are continuously innovating novel treatment options. Ke